Investigating genetic variations linked to aggressive prostate cancer in men of African and European ancestry
Contribution of germline copy number variations to the susceptibility of aggressive prostate cancer in men of African and European ancestry
['FUNDING_R01'] · UNIVERSITY OF SOUTHERN CALIFORNIA · NIH-11050373
This study is looking at how certain inherited genetic changes might increase the risk of aggressive prostate cancer in men from African and European backgrounds, so that we can better understand these risks and help patients learn more about their own genetic factors related to the disease.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF SOUTHERN CALIFORNIA (nih funded) |
| Locations | 1 site (Los Angeles, UNITED STATES) |
| Trial ID | NIH-11050373 on ClinicalTrials.gov |
What this research studies
This research focuses on understanding how inherited genetic variations, specifically germline copy number variations (CNVs), contribute to the risk of aggressive prostate cancer in men from African and European backgrounds. By utilizing advanced techniques such as imputation and sequencing, the study aims to identify both common and rare CNVs that may influence prostate cancer susceptibility. The research will analyze existing genetic data from large-scale studies to uncover critical insights into how these variations affect disease outcomes. Patients may benefit from a better understanding of their genetic risk factors for prostate cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are men of African or European ancestry who are at risk for or diagnosed with prostate cancer.
Not a fit: Patients who do not have prostate cancer or are not of African or European ancestry may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved risk assessment and personalized treatment strategies for prostate cancer patients.
How similar studies have performed: Previous studies have shown promise in identifying genetic variations linked to prostate cancer, but this research aims to explore a less studied area of germline CNVs, making it a novel approach.
Where this research is happening
Los Angeles, UNITED STATES
- UNIVERSITY OF SOUTHERN CALIFORNIA — Los Angeles, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CHEN, FEI — UNIVERSITY OF SOUTHERN CALIFORNIA
- Study coordinator: CHEN, FEI
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancer Cause, Cancer Etiology, Cancers, Candidate Disease Gene